Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
Clinical trial NCT05573698 · COMPLETED
Trial details
- NCT number
- NCT05573698
- Sponsor
- Design Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2023-08-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.